Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.


21 07, 2014

Cancer drug Nexavar: Why won’t myeloma researchers let go?

Tags: , , , |0 Comments

In 2012, researchers became excited about the possibility that a drug used to treat thyroid, liver and kidney cancer, sorafenib (Nexavar), might work on multiple myeloma, too.  I hadn't heard much about it--until last week. Here are the results of yet another laboratory study, published Friday on the resource site: Two death pathways induced

6 06, 2011

My Encouraging Visit With Onyx President & CEO, Dr. Anthony Coles

Tags: , , , , , |0 Comments

If I have time, I will report on some important myeloma related presentations at the American Society of Clinical Oncology (ASCO) meetings here in Chicago Sunday.  But first, I would like to share a some thoughts about a reception I attended Saturday evening at the Field Museum on Chicago's lakefront. Hosted by Onyx Pharmaceuticals, the elegant